Abstract:BACKGROUND: Endomorphin-1 and endo morphin-2 are endogenous peptides that are highly selective for A-opioid receptors. However, studies of their functional efficacy and selectivity are controversial. In this study, we systematically compared the effects of intrathecal (i.t.) administration of endomorphin-1 and -2 on nociception assays and G protein activation with those of [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephatin (DANIGO), a highly effective peptidic A-opioid receptor agonist. METHODS: Mate Sprague-Dawley rats were used. Acute and inflammatory pain models were used to compare the duration and magnitude of antinociception. Agonist-stimulated [S-35]GTP-gamma S binding was used to observe the functional activity at the level of the receptor-G protein in both spinal cord and thalamic membranes. In addition, antagonists selective for each receptor type were used to verify the functional selectivity of endomorphins in the rat spinal cord. RESULTS: After i.t. administration, endomorphin-1 and -2 produced less antinociceptive effects than DAMGO in the model of acute pain. Concentration-response curves for DAMGO-, enclomorphin-1-,and endomorphin-2-stimulated [S-35]GTP-gamma S binding revealed that both endomorphin-1 and -2 produced less G protein activation (i.e., approximately 50%-60%) than DAMGO did in the membranes of spinal cord and thalamus. In addition, i.t. endomorphin-induced antinociception was blocked by mu-opioid receptor selective dose of naltrexone (P < 0.05), but not by delta- and kappa-Opioid receptor antagonists, naltrindole and nor-binaltorphimine (P > 0.05). CONCLUSIONS: Endomorphins are partial agonists for G protein activation at spinal and thalamic mu-opioid receptors. Both in vivo and in vitro measurements together suggest that DAMGO is more effective than enclomorphins. Spinal endomorphins' antinociceptive efficacy may range between 53% and 84% depending on the intensity and modality of the nociceptive stimulus.

Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice.

In vivo characterization of the effects of ghrelin on the modulation of acute pain at the supraspinal level in mice.

Study on the Molecular Mechanism of Antinociception Induced by Ghrelin in Acute Pain in Mice

The Antinociceptive Effects and Molecular Mechanisms of Ghrelin(1–7)-Nh2 at the Supraspinal Level in Acute Pain in Mice

Attenuation of systemic morphine-induced analgesia by central administration of ghrelin and related peptides in mice.

Effects of Ghrelin on Pgsk-3Β and Β-Catenin Expression when Protects Against Neuropathic Pain Behavior in Rats Challenged with Chronic Constriction Injury

Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Gentiopicroside Attenuates Morphine Rewarding Effect Through Downregulation of Glun2b Receptors in Nucleus Accumbens

Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level.

Antinociceptive Efficacy of the µ-Opioid/Nociceptin Peptide-Based Hybrid KGNOP1 in Inflammatory Pain without Rewarding Effects in Mice: An Experimental Assessment and Molecular Docking

The Active Fragments of Ghrelin Cross the Blood-Brain Barrier and Enter the Brain to Produce Antinociceptive Effects after Systemic Administration

Supraspinal Hyperalgesia and Spinal Analgesia by [Phe1ψ(ch2-Nh)gly2]nociceptin-(1–13)-nh2 in Rat

The Spinal Antinociceptive Effects of Endomorphins in Rats: Behavioral and G Protein Functional Studies

Interleukin-2-induced Antinociception in Morphine-Insensitive Rats.

Neuropeptide S Produces Antinociceptive Effects at the Supraspinal Level in Mice

Pharmacologically Inhibiting Glur2 Internalization Alleviates Neuropathic Pain

Activation of Spinal Glucagon-Like Peptide-1 Receptors Specifically Suppresses Pain Hypersensitivity

Novel chimeric peptides based on endomorphins and ghrelin receptor antagonist produced supraspinal antinociceptive effects with reduced acute tolerance in mice

Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse

A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2

Effects and Mechanisms of Supraspinal Administration of Rat/mouse Hemokinin-1, a Mammalian Tachykinin Peptide, on Nociception in Mice